# Parexel International Corp.

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Parexel is one of the world's largest clinical research organizations, providing a full range of Phase I to IV clinical development services. They leverage extensive clinical, regulatory, and therapeutic expertise with a patient-first approach to design and deliver efficient and impactful clinical trials globally.

- Business Profile: https://optimly.ai/brand/parexel-international
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://parexel.com/
- Logo: https://logo.clearbit.com/parexel.com
- Slug: parexel-international
- Brand Authority Index tier: Emerging
- Archetype: Incumbent
- Category: Clinical Research Organization
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: In-house Clinical Development: Biopharmaceutical companies could manage clinical trials entirely with their internal teams, including regulatory affairs, trial design, site management, data collection | Specialized Clinical Consulting Firms: Companies might opt for smaller, specialized consulting firms for specific aspects of clinical trials, such as regulatory submissions, statistical analysis, or p | Limited or Delayed Drug Development: Without a CRO or robust internal capabilities, drug development efforts could be significantly limited, delayed, or fail to meet regulatory standards, preventing n
Solutions: Parexel clinical research organization | CRO services Phase I to IV | inflammation and immunology clinical trials | biopharmaceutical drug development | patient-centric clinical trials | Clinical Trial Management Software (CTMS): Instead of outsourcing, companies could license and implement various clinical trial management systems, Electronic Data Capture (EDC) systems, and other sof